Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 13951 - 13975 of 14521 in total
Experimental
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
Experimental
AMG-131 (T131), an orally-administered therapy, is expected to lower blood glucose in type II diabetic patients by improving the body’s ability to respond to insulin. T131 is a selective modulator of PPARg (peroxisome proliferator activated receptor gamma), a receptor involved in regulating the body’s ability to respond to insulin. T131...
Investigational
Matched Description: … is not structurally related to the thiazolidinedione class of PPARg agonists, which includes Actos and
Experimental
Netoglitazone (MCC-555) is a hypoglycemic agent.
Experimental
Displaying drugs 13951 - 13975 of 14521 in total